Tests of a vaccine from the Ebola showed the high immune answer

About 98 percent of participants of test of a vaccine against the Ebola showed the high immune answer, transfers British TV channel "Sky News". Tests took place to Sierra Leone. The answer of antibodies was visible in 21 days after introduction of the second dose, and its duration made not less than two years at adults. According to the research published in The Lancet by Infectious Diseases, the two-dose vaccine from Johnson & Johnson Inc. also was safe and well transferable. The research EBOVAC-Salone is the first test of a vaccine in the region, affected by the outbreak of fever the Ebola in 2014-2016, the heaviest for all...